Asymmetric dimethylarginine levels in patients with cutaneous anthrax: a laboratory analysis

Sünnetçioğlu, Mahmut; Mengeloglu, Zafer; Baran, Ali; Karahocagil, Mustafa; Tosun, Mehmet; Kucukbayrak, Abdulkadir; CEYLAN, Mehmet; Akdeniz, Hayrettin; AYPAK, Cenk

doi:10.1186/1476-0711-13-12

Asymmetric dimethylarginine levels in patients with cutaneous anthrax: a laboratory analysis

Sünnetçioğlu M., Mengeloglu Z., Baran A. İ., Karahocagil M., Tosun M., Kucukbayrak A., ...Daha Fazla

ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS, cilt.13, 2014 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 13
Basım Tarihi: 2014
Doi Numarası: 10.1186/1476-0711-13-12
Dergi Adı: ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
Van Yüzüncü Yıl Üniversitesi Adresli: Evet

Özet

Background: Asymmetric dimethylarginine (ADMA), the main endogenous inhibitor of nitric oxide synthase, is considered to be associated with endothelial dysfunction. High ADMA levels have been shown to be related with disorders causing vascular inflammation such as hypertension, hypercholesterolemia, atherosclerosis, chronic heart failure, stroke and sepsis. Cutaneous anthrax (CA) is a serious infectious disease which may cause vasculitis. The aim of the study was to investigate the serum ADMA levels in patients with CA.